SBRI funding competition: technology to improve IBD care and management
Organisations can apply for a share of up to £400,000 for innovative technology to improve inflammatory bowel disease care and management.
Documents
Details
This competition opened on 20 March 2017 and is now closed for registrations.
NHS Scotland, in conjunction with Highlands and Islands Enterprise and Scottish Government, will fund up to £400,000 for innovative technology and digital platforms that improve inflammatory bowel disease (IBD) care.
This is a Small Business Research Initiative (SBRI) competition. The aim is to develop technology that will improve the ongoing management of IBD for people living with the disease.
The competition is looking for proposals that:
- help patients manage their health from home
- promote independence and help people to be more involved in decisions about their care
- facilitate easier and quicker communication with clinicians
Organisations can carry out the project on their own or with others.
This competition has 3 phases. We have allocated up to £75,000 for phase 1, up to £135,000 for phase 2 and up to £150,000 for phase 3:
- phase 1: technical feasibility. Projects should last up to 8 weeks. Projects can range in size up to a total cost of £15,000 each
- phase 2: prototype development and testing. Projects should last up to 6 months. Projects can range in size up to a total cost of £45,000 each
- phase 3: pre-commercial testing to support continued development of the solution. Projects should last up to 1 year. Projects can range in size up to a total cost of £75,000 each
You must register before midday on 10 May 2017.
You must apply before midday on 17 May 2017.
Register to attend the briefing event in Inverness on 4 April 2017.
Not right for your innovation project? View other Innovate UK funding competitions.
Updates to this page
Published 10 February 2017Last updated 10 May 2017 + show all updates
-
Removed registration link.
-
Added the registration link and guidance for applicants.
-
First published.